Healthcare & Medical Devices Global On demand · 24-48h

Global Robotic Liquid Handling System Market Strategic Research Report

Global Robotic Liquid Handling System Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Robotic Liquid Handling System Market
$5.26B2025
6.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Machine, Consumable

By Application: Biopharmaceutical Company, Government Agency, Medical Institution, University and Research Institute, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Eppendorf, Thermo Fisher Scientific, PerkinElmer, Agilent, Labcyte, Tecan, Corning, Aurora Biomed, Analytik Jena, BRAND GMBH, Hudson Robotics, BICO, Revvity, Beckman Coulter, Hamilton, Formulatrix, SPT Labtech, Tiangen Biotech (Beijing), Beijing AMTK Technology Development, Ashmar Scientific (Shanghai), Nanjing Vazyme Biotech, Suzhou PRCXI Biotechnology, NAYO Biotechnology (Shanghai)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 162 pages
Market size 2025
$5.26B
Billion USD
Forecast CAGR
6.6%
2025-2032
Forecast 2032
$8.2B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Robotic Liquid Handling System market size is predicted to grow from US$ 5,263 million in 2025 to US$ 8,186 million in 2032; it is expected to grow at a CAGR of 6.6% from 2026 to 2032.

In 2025, global Robotic Liquid Handling System production reached approximately 3627.1 k sets with an average global market price of around k US$105 per set. Single-line annual production capacity averages 5000 sets with a gross margin of approximately 32-35%. The upstream of the Robotic Liquid Handling System industry includes core components such as precision machinery, control systems, and sensors, which are primarily concentrated in the fields of precision machinery manufacturing and automation; the downstream applications cover biopharmaceutical companies, government agencies, medical institutions, universities, and research institutions, among which biopharmaceutical companies and medical institutions account for the highest consumption, approximately 60%; with the deepening of life science research and the increasing number of clinical trials, the demand for Robotic Liquid Handling Systems is continuously growing, and the business opportunities lie in technological innovation and the provision of customized solutions.

The Robotic Liquid Handling System is an advanced technological solution designed to automate the precise manipulation of liquids in a variety of applications. It encompasses a suite of components that include robotic arms, sensors, and control software, which collectively enable the system to perform tasks such as pipetting, dispensing, and mixing with high accuracy and consistency. The system is engineered to improve efficiency, reduce human error, and enhance safety in environments where the handling of liquids is critical, such as in laboratories, pharmaceutical manufacturing, and biotechnology research.

The future of the Robotic Liquid Handling System industry is poised to witness a surge in technological innovation, leading to more precise, flexible, and efficient systems. Customized solutions will cater to diverse industry needs, while the integration of AI and ML will enhance system adaptability and performance. A trend towards integration with other lab equipment and production processes will streamline workflows, and safety measures will be further enhanced to protect both personnel and equipment. With the advent of remote monitoring and maintenance through IoT and cloud computing, system availability and reliability will improve. Environmental sustainability and cost-effectiveness will also play significant roles, as will the compliance with global and regional regulations, driving the industry towards a more advanced and universally accessible landscape.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Robotic Liquid Handling System market?

What factors are driving Robotic Liquid Handling System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Robotic Liquid Handling System market opportunities vary by end market size?

How does Robotic Liquid Handling System break out by Type, by Application?

This report presents a comprehensive overview of the global Robotic Liquid Handling System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Machine
  • Consumable

Segment by Accuracy

  • Milliliter(mL)
  • Microliter(μL)
  • Nanoliter(nL)
  • Picoliter(pL)

Segment by Handling Method

  • Non-contact Workstation
  • Contact Workstation

Segment by Application

  • Biopharmaceutical Company
  • Government Agency
  • Medical Institution
  • University and Research Institute
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Robotic Liquid Handling System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biopharmaceutical Company, Government Agency, Medical Institution evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Robotic Liquid Handling System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$5.26B
2025
Forecast
$8.2B
2032
CAGR
6.6%
2025–2032
영역들
5
global
Key companies
EppendorfThermo Fisher ScientificPerkinElmerAgilentLabcyteTecanCorningAurora Biomed
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
MachineConsumable
By Application
Biopharmaceutical CompanyGovernment AgencyMedical InstitutionUniversity and Research InstituteOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Machine
  • 3.1.3 Consumable
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biopharmaceutical Company
  • 4.1.3 Government Agency
  • 4.1.4 Medical Institution
  • 4.1.5 University and Research Institute
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Eppendorf
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher Scientific
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 PerkinElmer
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Agilent
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Labcyte
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Tecan
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Corning
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Aurora Biomed
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Analytik Jena
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 BRAND GMBH
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hudson Robotics
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 BICO
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Revvity
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Beckman Coulter
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Hamilton
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Formulatrix
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 SPT Labtech
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Tiangen Biotech (Beijing)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Beijing AMTK Technology Development
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Ashmar Scientific (Shanghai)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Nanjing Vazyme Biotech
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Suzhou PRCXI Biotechnology
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 NAYO Biotechnology (Shanghai)
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Robotic Liquid Handling System market size?
The global Robotic Liquid Handling System market is estimated at US$ 5.26 billion in 2025 (base year) and is projected to reach US$ 8.19 billion by 2032.
What growth rate is expected for the Robotic Liquid Handling System market through 2032?
The market is expected to grow at a CAGR of 6.6% from 2026 to 2032, expanding from US$ 5.26 billion in 2025 to US$ 8.19 billion in 2032, roughly 1.6 times its base-year value.
How is Robotic Liquid Handling System defined?
In 2025, global Robotic Liquid Handling System production reached approximately 3627.1 k sets with an average global market price of around k US$105 per set. Single-line annual production capacity averages 5000 sets with a gross margin of approximately 32-35%.
How is the Robotic Liquid Handling System market segmented by type?
By type, the market is segmented into Machine and Consumable.
What are the key applications of Robotic Liquid Handling System?
Key applications covered include Biopharmaceutical Company, Government Agency, Medical Institution, University and Research Institute and Others.
Which companies are profiled in the Robotic Liquid Handling System market report?
Key players profiled include Eppendorf, Thermo Fisher Scientific, PerkinElmer, Agilent, Labcyte, Tecan, Corning and Aurora Biomed, among 23 companies covered in total.
What geographies does the Robotic Liquid Handling System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Robotic Liquid Handling System?
Environmental sustainability and cost-effectiveness will also play significant roles, as will the compliance with global and regional regulations, driving the industry towards a more advanced and universally accessible landscape.
Who should buy the Robotic Liquid Handling System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biopharmaceutical Company, Government Agency and Medical Institution, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Robotic Liquid Handling System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.